Anzeige
Mehr »
Login
Samstag, 28.11.2020 Börsentäglich über 12.000 News von 646 internationalen Medien
Diese Firma ist einfach nicht zu stoppen! Top-News am laufenden Band!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1H68T ISIN: US6951271005 Ticker-Symbol: 82P 
Tradegate
27.11.20
17:30 Uhr
53,50 Euro
0,00
0,00 %
1-Jahres-Chart
PACIRA BIOSCIENCES INC Chart 1 Jahr
5-Tage-Chart
PACIRA BIOSCIENCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
52,5054,0012:37
53,0053,5027.11.

Aktuelle News zur PACIRA BIOSCIENCES Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
PACIRA BIOSCIENCES Aktie jetzt für 0€ handeln
19.11.Pacira (PCRX) Gets European Commission Approval for Exparel2
18.11.Pacira's postsurgical pain med Ok'd in Europe-
18.11.Pacira Pharmaceuticals, Inc.: Pacira Receives European Commission Approval for EXPAREL (bupivacaine liposome injectable suspension) for the Treatment ...-
12.11.Pacira BioSciences, Inc. - 8-K, Current Report1
11.11.Pacira Pharmaceuticals, Inc.: Pacira BioSciences Reports Preliminary Net Product Sales of $41.7 Million for October 20201
30.10.Pacira's (PCRX) Q3 Earnings Top Estimates, Revenues Rise Y/Y-
29.10.Pacira BioSciences, Inc. (PCRX) CEO David Stack on Q3 2020 Results - Earnings Call Transcript1
29.10.Pacira BioSciences, Inc. 2020 Q3 - Results - Earnings Call Presentation2
29.10.Pacira BioSciences, Inc. - 8-K, Current Report1
29.10.Pacira BioSciences EPS beats by $0.03, beats on revenue-
29.10.Pacira Pharmaceuticals, Inc.: Pacira BioSciences Reports Third Quarter 2020 Financial Results and Business Update-
21.10.Pacira Pharmaceuticals, Inc.: Pacira Launches State-of-the-Art Training Center Dedicated to Advancing Best Practice Regional Approaches to Manage Acute ...-
20.10.Pacira Pharmaceuticals, Inc.: Pacira to Report Third Quarter 2020 Financial Results on Thursday October 29, 20201
07.10.Pacira Bio sees Exparel sales of $113.7M for Q3 20201
07.10.Pacira BioSciences, Inc. - 8-K, Current Report-
23.09.Pacira BioSciences: Products And Management Can Maintain Outperformance Despite Q2 Sales Decline2
21.09.Pacira (PCRX) Gains Positive CHMP Opinion for Exparel in EU3
18.09.Pacira Pharmaceuticals, Inc.: Pacira Receives Positive CHMP Opinion for EXPAREL (bupivacaine liposome injectable suspension) for the Treatment of Postsurgical ...1
15.09.Pacira Pharmaceuticals, Inc.: IPG and Pacira BioSciences Announce Collaboration to Reduce Postsurgical Opioid Prescribing and Surgical Procedure Costs-
09.09.Pacira BioSciences, Inc. - 8-K, Current Report-
Seite:  Weiter >>
42 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1